Fluorescent tracer agents coupled with transdermal detection technology enable physiological monitoring.
More >>
Bright fluorescent agents designed not to interact with the body are sensed through the skin.
More >>
New clinical applications for fluorescent tracer agent-based systems are in development.
More >>
Clinical and preclinical studies are underway to advance the use of fluorescence to measure and monitor disease progression.
More >>
Composition of matter, algorithm, and method patents are a platform for continued innovation.
More >>
Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology.
More >>
Fluorescent agents engineered to not interact with the body have the potential to enable measurement and monitoring of vital organ systems.
More >>
Measurement of GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate real-time point of care methodology holds promise.
More >>
Increased intestinal permeability is implicated in inflammatory bowel disease. Rapid assessment of gut barrier function is a focus.
More >>
Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis.
More >>
Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization.
More >>
Potential medical applications for fluorescent tracer agent-based systems are wide ranging and target important unmet patient needs.
More >>
Technology whose development began inside leading medical technology companies is nearing human application today.
More >>
Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health.
More >>
Investment in fluorescence-based systems target multiple multi-billion dollar unmet medical needs.
More >>
Our approach to quality concentrates on the integrity of processes and preventive measures.
More >>
Transdermal GFR technology is used extensively in preclinical (animal) nephrology research. MediBeacon technology is used by leading medical schools, academic centers, research institutes, contract research organizations, and pharmaceutical companies worldwide to enhance preclinical assessment of kidney therapeutics, evaluate nephrotoxicity, and gain a fundamental understanding of kidney function in animals. Research using the Transdermal GFR Monitor has been featured at scientific meetings worldwide.
